Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion ( AMPLE )‐2 randomized trial
Respirology · 2023
DOI: 10.1111/resp.14451 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Respirology, 2023. Verfasst von Carolyn J Peddle-McIntyre und 7 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Council Western Australia.
Abstract (Originalsprache)
Background and Objective Device‐assessed activity behaviours are a novel measure for comparing intervention outcomes in patients with malignant pleural effusion (MPE). Australasian Malignant PLeural Effusion (AMPLE)‐2 was a multi‐centre clinical trial where participants with MPE treated with an indwelling pleural catheter were randomized to daily (DD) or symptom‐guided (SGD) drainage for 60‐days. Our aim was to describe activity behaviour patterns in MPE patients, explore the impact of drainage regimen on activity behaviours and examine associations between activity behaviours and quality of life (QoL).
Methods
Following randomization to DD or SGD, participants enrolled at the lead site (Perth) completed accelerometry assessment. This was repeated monthly for 5‐months. Activity behaviour outcomes were calculated as percent of daily waking‐wear time and compared between groups (Mann–Whitney U test; Median [IQR]). Correlations between activity behaviour outcomes and QoL were examined.
Results
Forty‐one (91%) participants provided ≥1 valid accelerometry assessment (DD n = 20, SGD n = 21). Participants spent a large proportion of waking hours sedentary (72%–74% across timepoints), and very little time in moderate‐to‐vigorous physical activity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
- Department of Respiratory Medicine, Northern Hospital, Melbourne, Victoria, Australia.
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
- School of Allied Health, Curtin University, Bentley, Western Australia, Australia.
- Movement Physiology Laboratory, School of Physiology, University of Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Carolyn J Peddle-McIntyre, Sanjeevan Muruganandan, Joanne McVeigh, Deirdre B Fitzgerald, Leon Straker, Robert U Newton, Kevin Murray, Yun Chor Gary Lee
Förderung
- Cancer Council Western Australia
Zitieren
APA
Peddle-McIntyre, C. J., Muruganandan, S., McVeigh, J., Fitzgerald, D. B., Straker, L., Newton, R. U., Murray, K., & Lee, Y. C. G. (2023). Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion ( AMPLE )‐2 randomized trial. Respirology. https://doi.org/10.1111/resp.14451
Vancouver
Peddle-McIntyre CJ, Muruganandan S, McVeigh J, Fitzgerald DB, Straker L, Newton RU, et al. Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion ( AMPLE )‐2 randomized trial. Respirology. 2023. doi:10.1111/resp.14451
BibTeX
@article{PeddleMcIntyre2023,
author = {Peddle-McIntyre, Carolyn J and Muruganandan, Sanjeevan and McVeigh, Joanne and Fitzgerald, Deirdre B and Straker, Leon and Newton, Robert U and Murray, Kevin and Lee, Yun Chor Gary},
title = {Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion ( AMPLE )‐2 randomized trial},
journal = {Respirology},
year = {2023},
doi = {10.1111/resp.14451}
}
EUVIMED